Giulio Ricotta

No ORCID on file · 4 papers in corpus · active 2021-2026

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 1
article 2026
Adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies is associated with improved survival in patients with pelvic lymph node metastasis: a sub-analysis from the COREPEX study
·doi:10.1016/j.ijgc.2025.103065
article 2022
2022-RA-173-ESGO Endometrioid borderline ovarian tumor: clinical characteristics, prognosis and management
·doi:10.1136/ijgc-2022-esgo.480
other 2022
Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements
Annals of surgical oncology ·doi:10.1245/s10434-022-11893-7

BACKGROUND: Endometrioid borderline ovarian tumor (EBOT) is a rare subtype of borderline ovarian malignancies. This study was designed to determine the prognosis of a series of EBOT. METHODS: This is a retrospective review of patients with…

article 2021
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management
Annals of surgical oncology ·doi:10.1245/s10434-021-10776-7